Rockwell Medical Announces 1-for-10 Reverse Stock Split

About this update from Rockwell Medical, Inc.

Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that its Board of Directors (the "Board") has authorized a 1-for-10 reverse split of the Company's issued and outstanding common stock (the "Reverse Stock Split"). The Board received approval at the Company's Annual Meeting of Stockholders on June 12, 2026 to approve and adopt an amendment to the Company's Certificate of Incorporation to effect a reverse stock split of the Company's common stock. The Reverse Stock Split will become effective at 12:01 a.m. EDT on July 1, 2026. The Company's common stock will continue to trade under the symbol "RMTI" on the Nasdaq Capital Market. The new CUSIP number following the Reverse Stock Split will be 774374409. "The Reverse Stock Split is primarily intended to bring the Company into compliance with the minimum bid price requirement of $1.00 per share for continued listing on Nasdaq. Rockwell Medical's Board of Directors believes that maintaining the listing of the Company's common stock on Nasdaq is in the best interests of the Company and its stockholders. Continued listing on Nasdaq can provide, among other benefits, enhanced liquidity for our common stock, broader access to capital, increased visibility in the marketplace, and the ability to attract and retain institutional investors," said Robert S. Radie, Chairman of the Board at Rockwell Medical. When the Reverse Stock Split becomes effective on July 1, 2026, every ten (10) shares of the Company's common stock issued and outstanding will be automatically reclassified into one (1) new share of common stock. The Reverse Stock Split will not modify any rights or preferences of the shares of the Company's common stock. Proportionate adjustments will be made to the exercise prices and the number of shares underlying the Company's outstanding equity awards, as applicable, warrants, and convertible preferred stock, as well as to the number of shares issued and issuable under the Company's equity incentive plans. The common stock issued pursuant to the Reverse Stock Split will remain paid and non-assessable. The Reverse Stock Split will not affect the number of authorized shares of common stock of the Company authorized under the Company's Certifica...

View stock analysis, news, and events for Rockwell Medical, Inc.